Stress Reduction in Ovarian Cancer

Completed · Not applicable

Conditions studied: Ovarian, Fallopian, and Primary Peritoneal Cancer

In brief

The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.

Key facts

Study ID: NCT01790789
Run by: University of Wisconsin, Madison
People needed: 41
Starts: 2013-02-01
Expected to finish: 2016-12-06
Last updated by the study team: 2019-11-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

Subjects must have an initial diagnosis of ovarian, fallopian tube or primary peritoneal cancer who completed primary ovarian cancer surgery or 3 cycles of neoadjuvant chemotherapy with interval cytoreductive surgery (ICS).
Final pathology diagnosis of stage I-IV ovarian, fallopian tube or primary peritoneal cancer with plan to receive primary adjuvant chemotherapy or completion of chemotherapy after ICS.
Receive chemotherapy at the University of Wisconsin-Madison.
Subjects must be at least 18 years of age.
English-speaking
Subjects must be able to use audio media, and read and understand the study manual.
ECOG performance status 0-2.
Subjects must have a phone.

You may not qualify if…

Subjects participating in a meditation practice more than 1 hour per week prior to surgery and/or chemotherapy administration.
Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer.
Subjects with diagnosis of Chronic Fatigue Syndrome (CFS).
Subjects unable to use audio media due to auditory dysfunction.
Subjects unable to read written English.
Subjects who are prisoners or incarcerated.

Where it is running

University of Wisconsin School of Medicine and Public Health — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.